IgY-based antivenom against Bothrops alternatus: Production and neutralization efficacy

Antivenom for the treatment of bothropic snakebite is a priority for public health institutions from Latin America. An alternative to the conventional antivenom production is based on the use of egg yolk antibodies – IgY-technology – by immunizing laying hens. In this study, we produced, characterized and assessed the efficacy of IgY-based antivenoms against B. alternatus venom. Immunochemical studies (reactivity, avidity and antigen recognition pattern) as well as antivenom efficacy assays were performed. After the 3rd immunization, levels of specific IgY reached a maximum that was maintained throughout the observation period, while avidity indexes of the extracts increased after the successive immunizations. Furthermore, IgY against B. alternatus recognized protein complexes of the venom with high (>40 kDa), medium (20–40 kDa) and low (<20 kDa) molecular weights. IgY antivenoms obtained after 8 immunizations neutralized 35.65 μg of B. alternatus venom per mg of antivenom, while specific activities values ranged from 0.28 to 0.42. In conclusion, we produced and characterized IgY antivenoms capable of neutralizing the lethal activity of B. alternatus venom at a preclinical level. Thus, IgY-technology may allow the production of effective and affordable antivenoms fulfilling the urgent needs of many countries where conventional manufacture is unable to provide enough availability of antivenoms.

Saved in:
Bibliographic Details
Main Authors: Leiva, Carlos Leónidas, Cangelosi, Adriana, Mariconda, Virginia, Farace, Mariano, Geoghegan, Patricia, Brero, Luisa, Fernandez Miyakawa, Mariano Enrique, Chacana, Pablo Anibal
Format: info:ar-repo/semantics/artículo biblioteca
Language:eng
Published: Elsevier 2019-05
Subjects:Egg Yolk, Snake Bites, Venoms, Antigens, Yema de Huevo, Mordeduras de Serpientes, Venenos, Antígenos, Bothrops alternatus, Veneno de Serpiente, Anticuerpo IgY, Neutralización del Veneno, Snake Venom, IgY Antibody, Venom Neutralization,
Online Access:https://www.sciencedirect.com/science/article/pii/S0041010119300972
http://hdl.handle.net/20.500.12123/5141
https://doi.org/10.1016/j.toxicon.2019.03.020
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:localhost:20.500.12123-5141
record_format koha
spelling oai:localhost:20.500.12123-51412019-06-10T18:16:37Z IgY-based antivenom against Bothrops alternatus: Production and neutralization efficacy Leiva, Carlos Leónidas Cangelosi, Adriana Mariconda, Virginia Farace, Mariano Geoghegan, Patricia Brero, Luisa Fernandez Miyakawa, Mariano Enrique Chacana, Pablo Anibal Egg Yolk Snake Bites Venoms Antigens Yema de Huevo Mordeduras de Serpientes Venenos Antígenos Bothrops alternatus Veneno de Serpiente Anticuerpo IgY Neutralización del Veneno Snake Venom IgY Antibody Venom Neutralization Antivenom for the treatment of bothropic snakebite is a priority for public health institutions from Latin America. An alternative to the conventional antivenom production is based on the use of egg yolk antibodies – IgY-technology – by immunizing laying hens. In this study, we produced, characterized and assessed the efficacy of IgY-based antivenoms against B. alternatus venom. Immunochemical studies (reactivity, avidity and antigen recognition pattern) as well as antivenom efficacy assays were performed. After the 3rd immunization, levels of specific IgY reached a maximum that was maintained throughout the observation period, while avidity indexes of the extracts increased after the successive immunizations. Furthermore, IgY against B. alternatus recognized protein complexes of the venom with high (>40 kDa), medium (20–40 kDa) and low (<20 kDa) molecular weights. IgY antivenoms obtained after 8 immunizations neutralized 35.65 μg of B. alternatus venom per mg of antivenom, while specific activities values ranged from 0.28 to 0.42. In conclusion, we produced and characterized IgY antivenoms capable of neutralizing the lethal activity of B. alternatus venom at a preclinical level. Thus, IgY-technology may allow the production of effective and affordable antivenoms fulfilling the urgent needs of many countries where conventional manufacture is unable to provide enough availability of antivenoms. Instituto de Patobiología Fil: Leiva, Carlos. Instituto Nacional de Tecnología Agropecuaria (INTA). Instituto de Patobiología; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina Fil: Cangelosi, Adriana. Ministerio de Salud. Administración Nacional de Laboratorios e Institutos de Salud “Dr. Carlos G. Malbrán”. Centro Nacional de Control de Calidad de Biológicos; Argentina Fil: Mariconda, Virginia. Ministerio de Salud. Administración Nacional de Laboratorios e Institutos de Salud “Dr. Carlos G. Malbrán”. Centro Nacional de Control de Calidad de Biológicos; Argentina Fil: Farace, Mariano. Instituto Nacional de Tecnología Agropecuaria (INTA). Instituto de Patobiología; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina Fil: Geoghegan, Patricia. Ministerio de Salud. Administración Nacional de Laboratorios e Institutos de Salud “Dr. Carlos G. Malbrán”. Centro Nacional de Control de Calidad de Biológicos; Argentina Fil: Brero, Luisa. Ministerio de Salud. Administración Nacional de Laboratorios e Institutos de Salud “Dr. Carlos G. Malbrán”. Centro Nacional de Control de Calidad de Biológicos; Argentina Fil: Fernandez Miyakawa, Mariano Enrique. Instituto Nacional de Tecnología Agropecuaria (INTA). Instituto de Patobiología; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina Fil: Chacana, Pablo. Instituto Nacional de Tecnología Agropecuaria (INTA). Instituto de Patobiología; Argentina 2019-05-17T13:07:57Z 2019-05-17T13:07:57Z 2019-05 info:ar-repo/semantics/artículo info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion https://www.sciencedirect.com/science/article/pii/S0041010119300972 http://hdl.handle.net/20.500.12123/5141 0041-0101 https://doi.org/10.1016/j.toxicon.2019.03.020 eng info:eu-repo/semantics/restrictedAccess application/pdf Elsevier Toxicon 163 : 84-92 (Mayo 2019)
institution INTA AR
collection DSpace
country Argentina
countrycode AR
component Bibliográfico
access En linea
databasecode dig-inta-ar
tag biblioteca
region America del Sur
libraryname Biblioteca Central del INTA Argentina
language eng
topic Egg Yolk
Snake Bites
Venoms
Antigens
Yema de Huevo
Mordeduras de Serpientes
Venenos
Antígenos
Bothrops alternatus
Veneno de Serpiente
Anticuerpo IgY
Neutralización del Veneno
Snake Venom
IgY Antibody
Venom Neutralization
Egg Yolk
Snake Bites
Venoms
Antigens
Yema de Huevo
Mordeduras de Serpientes
Venenos
Antígenos
Bothrops alternatus
Veneno de Serpiente
Anticuerpo IgY
Neutralización del Veneno
Snake Venom
IgY Antibody
Venom Neutralization
spellingShingle Egg Yolk
Snake Bites
Venoms
Antigens
Yema de Huevo
Mordeduras de Serpientes
Venenos
Antígenos
Bothrops alternatus
Veneno de Serpiente
Anticuerpo IgY
Neutralización del Veneno
Snake Venom
IgY Antibody
Venom Neutralization
Egg Yolk
Snake Bites
Venoms
Antigens
Yema de Huevo
Mordeduras de Serpientes
Venenos
Antígenos
Bothrops alternatus
Veneno de Serpiente
Anticuerpo IgY
Neutralización del Veneno
Snake Venom
IgY Antibody
Venom Neutralization
Leiva, Carlos Leónidas
Cangelosi, Adriana
Mariconda, Virginia
Farace, Mariano
Geoghegan, Patricia
Brero, Luisa
Fernandez Miyakawa, Mariano Enrique
Chacana, Pablo Anibal
IgY-based antivenom against Bothrops alternatus: Production and neutralization efficacy
description Antivenom for the treatment of bothropic snakebite is a priority for public health institutions from Latin America. An alternative to the conventional antivenom production is based on the use of egg yolk antibodies – IgY-technology – by immunizing laying hens. In this study, we produced, characterized and assessed the efficacy of IgY-based antivenoms against B. alternatus venom. Immunochemical studies (reactivity, avidity and antigen recognition pattern) as well as antivenom efficacy assays were performed. After the 3rd immunization, levels of specific IgY reached a maximum that was maintained throughout the observation period, while avidity indexes of the extracts increased after the successive immunizations. Furthermore, IgY against B. alternatus recognized protein complexes of the venom with high (>40 kDa), medium (20–40 kDa) and low (<20 kDa) molecular weights. IgY antivenoms obtained after 8 immunizations neutralized 35.65 μg of B. alternatus venom per mg of antivenom, while specific activities values ranged from 0.28 to 0.42. In conclusion, we produced and characterized IgY antivenoms capable of neutralizing the lethal activity of B. alternatus venom at a preclinical level. Thus, IgY-technology may allow the production of effective and affordable antivenoms fulfilling the urgent needs of many countries where conventional manufacture is unable to provide enough availability of antivenoms.
format info:ar-repo/semantics/artículo
topic_facet Egg Yolk
Snake Bites
Venoms
Antigens
Yema de Huevo
Mordeduras de Serpientes
Venenos
Antígenos
Bothrops alternatus
Veneno de Serpiente
Anticuerpo IgY
Neutralización del Veneno
Snake Venom
IgY Antibody
Venom Neutralization
author Leiva, Carlos Leónidas
Cangelosi, Adriana
Mariconda, Virginia
Farace, Mariano
Geoghegan, Patricia
Brero, Luisa
Fernandez Miyakawa, Mariano Enrique
Chacana, Pablo Anibal
author_facet Leiva, Carlos Leónidas
Cangelosi, Adriana
Mariconda, Virginia
Farace, Mariano
Geoghegan, Patricia
Brero, Luisa
Fernandez Miyakawa, Mariano Enrique
Chacana, Pablo Anibal
author_sort Leiva, Carlos Leónidas
title IgY-based antivenom against Bothrops alternatus: Production and neutralization efficacy
title_short IgY-based antivenom against Bothrops alternatus: Production and neutralization efficacy
title_full IgY-based antivenom against Bothrops alternatus: Production and neutralization efficacy
title_fullStr IgY-based antivenom against Bothrops alternatus: Production and neutralization efficacy
title_full_unstemmed IgY-based antivenom against Bothrops alternatus: Production and neutralization efficacy
title_sort igy-based antivenom against bothrops alternatus: production and neutralization efficacy
publisher Elsevier
publishDate 2019-05
url https://www.sciencedirect.com/science/article/pii/S0041010119300972
http://hdl.handle.net/20.500.12123/5141
https://doi.org/10.1016/j.toxicon.2019.03.020
work_keys_str_mv AT leivacarlosleonidas igybasedantivenomagainstbothropsalternatusproductionandneutralizationefficacy
AT cangelosiadriana igybasedantivenomagainstbothropsalternatusproductionandneutralizationefficacy
AT maricondavirginia igybasedantivenomagainstbothropsalternatusproductionandneutralizationefficacy
AT faracemariano igybasedantivenomagainstbothropsalternatusproductionandneutralizationefficacy
AT geogheganpatricia igybasedantivenomagainstbothropsalternatusproductionandneutralizationefficacy
AT breroluisa igybasedantivenomagainstbothropsalternatusproductionandneutralizationefficacy
AT fernandezmiyakawamarianoenrique igybasedantivenomagainstbothropsalternatusproductionandneutralizationefficacy
AT chacanapabloanibal igybasedantivenomagainstbothropsalternatusproductionandneutralizationefficacy
_version_ 1756007478035742720